Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shahana Dilruba"'
Autor:
Shahana Dilruba, Alessia Grondana, Anke C. Schiedel, Naoto T. Ueno, Chandra Bartholomeusz, Jindrich Cinatl Jr, Katie-May McLaughlin, Mark N. Wass, Martin Michaelis, Ganna V. Kalayda
Publikováno v:
Cells, Vol 9, Iss 2, p 515 (2020)
The efficacy of cisplatin-based chemotherapy in ovarian cancer is often limited by the development of drug resistance. In most ovarian cancer cells, cisplatin activates extracellular signal-regulated kinase1/2 (ERK1/2) signalling. Phosphoprotein enri
Externí odkaz:
https://doaj.org/article/d7ca6759aa7441a4bb97161a2063f3b4
Autor:
Naoto T. Ueno, Ganna V. Kalayda, Alessia Grondana, Katie-May McLaughlin, Martin Michaelis, Shahana Dilruba, Mark N. Wass, Anke C. Schiedel, Chandra Bartholomeusz, Jindrich Cinatl
Publikováno v:
Cells
Volume 9
Issue 2
Cells, Vol 9, Iss 2, p 515 (2020)
Volume 9
Issue 2
Cells, Vol 9, Iss 2, p 515 (2020)
The efficacy of cisplatin-based chemotherapy in ovarian cancer is often limited by the development of drug resistance. In most ovarian cancer cells, cisplatin activates extracellular signal-regulated kinase1/2 (ERK1/2) signalling. Phosphoprotein enri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ad9ce227f717c81aefd35f65461b94
https://kar.kent.ac.uk/80336/1/cells-09-00515-v2.pdf
https://kar.kent.ac.uk/80336/1/cells-09-00515-v2.pdf
Autor:
Ganna V. Kalayda, Shahana Dilruba
Publikováno v:
Cancer Chemotherapy and Pharmacology. 77:1103-1124
Platinum-based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment. Much effort h
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 53:1041-1045
Autor:
Shahana Dilruba, Thomas Berger, Günther Reitz, Astrid Adrian, Luis F. Spitta, Corinna Panitz, Sebastian Feles, Sebastian Diegeler, Claudia Schmitz, Bikash Konda, Markus Franz, Bernd Henschenmacher, Christine E. Hellweg, Bartos Przybyla, Jürgen Segerer, Luca Briganti, Christa Baumstark-Khan
One factor contributing to the high uncertainty in radiation risk assessment for long-term space missions is the insufficient knowledge about possible interactions of radiation with other spaceflight environmental factors. Such factors, e.g. microgra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63d5427913d3877cb909ddb5c067ea9a
https://doi.org/10.1016/j.lssr.2015.10.003
https://doi.org/10.1016/j.lssr.2015.10.003